Pre-market analysis
1)Nifty closed at 11050.25 and banknifty closed at 20982.35. 2)Global markets closed positive on friday. |
3)Today, US and Europe futures are trading positive and asian markets are trading positive and sgx nifty future is trading at 11077.50 up 0.34%.
4) We may open gap up of around 50-70 pts and follow global futures as the day progresses. as expected theere was huge shortcovering rally on friday and we closed above 11k.Today being important day for banknifty sc verdict, day will be volatile,for our upward journey towards 11500-11800,bnf needs to support.
5)Support and resistance for nifty and banknifty
6)Nifty option pain is at 11000 and banknifty option pain is at 20900.
7)Nifty may trade between 10800 and 11500 and banknifty may trade between 20500 and 21500 for this week.this are very strong support and resistances as per oi chain.
8)Results today
No result announcement of any important company.
9)Stocks in news
BergerPaints
The company says that the sales for Q2 will be higher than the previous quarter while Q3 sales will be better than the Q2
DeepakFertilisers
The company to meet on September 30 to consider the allotment of the second tranche of FCCB worth $15 million
Dr.Reddy's
Launched Tecfidera tablets in the US markets
CourtCasesToday
Interest waiver case in SC at 10:30am
ITC / GODFREY PHILLIPS / VST INDUSTRIES / GOLDEN TOBACCO
Maharashtra bans the sale of Loose Cigarettes and Beedis
This notification was issued by the state public health
department on Thursday
Becomes the first state in the country to do so
#PFIZER
Pfizer Inc’s Covid Vaccine Clinical Trial to yield conclusive results in October
Puts the company ahead of Moderna and Astrazeneca in the race of the vaccine
INDOCO REMEDIES
Launches FEVINDO 400 (Favipiravir 400mg Tablets) In India
Fevindo ‐ 400 (Favipiravir) is an antiviral drug, effective against the RNA‐based influenza virus
The drug has been approved by DCGI in the treatment of Covid‐2019
Cadila Healthcare
Received final approval from the U.S. FDA to market Dimethyl Fumarate Delayed-Release Capsules. The U.S. FDA has also allowed Zydus to be eligible for 180 days of generic drug exclusivity.
Granules
the U.S. FDA has approved its ANDA for Naproxen Sodium & Diphenhydramine Hydrochloride Tablets.
Cipla
received final approval for the generic version of Biogen IDEC's Tecfidera capsules from the U.S. FDA. The drug is used in the treatment of relapsing forms of multiple sclerosis.
10)Results
No results update
11)Happy Trading
12)Follow our telegram channel 'Optionstraders' for calls on equity and options.
Comments
Post a Comment